Claus Crone Fuglsang, Novonesis 🇩🇰 | Biosolutions, Industrial biotech, Synbio | E53

Novonesis arose from a 2023 merger of Novozymes and Chr Hansen, and is a highly profitable powerhouse. CSO Claus talks about the applications of Novonesis’ technology, its low profile among consumers, and how hard it is for biosolutions startups to scale up.
⭐️ ABOUT THE SPEAKER
Claus first joined Novozymes in 1993 and led its R&D both in Denmark and the US, with six years as CSO. He has a Master’s degree in biochemistry and an MBA.
🔗 LINKS MENTIONED
• Novonesis’ website — novonesis.com/en
• Merger of Novozymes and Chr Hansen — novonesis.com/en/news/novozymes-and-chr-hansen…
• Novonesis’ nine-month results in 2025 — backend.novonesis.com/sites/default/files/docu…
• Novonesis and Benchling partnership in 2024 — benchling.com/news/novonesis-and-benchling-lon…
• EU biosolutions — research-and-innovation.ec.europa.eu/research-…

📜 TRANSCRIPT

Read the full transcript here: flot.bio/episode/claus-crone-fuglsang-novonesi…

📖 SHORT BLOGS BASED ON THIS EPISODE:
• How AI, AlphaFold and Digital Twins are Transforming Biosolutions: flot.bio/ai-biosolutions-claus-crone-fuglsang

💸 DONATE
We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: paypal.me/PhilipHemme
⭐️ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!
🫶 FOLLOW US
• Newsletter: eepurl.com/h_fnmH
• LinkedIn: linkedin.com/company/flot-bio
• X (Twitter): x.com/FlotBio
🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
🎙️ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.
⏰ TIMESTAMPS
• [00:00:00] Intro
• [00:02:19] Novonesis: the Novozymes and Chr Hansen merger
• [00:09:51] Under the consumer radar
• [00:12:52] Business divisions and myriad applications
• [00:20:46] The scaling challenge in biosolutions
• [00:27:39] Novonesis’ profitability and growth
• [00:36:34] Genetic engineering and cool patents
• [00:47:57] Novonesis’ growing AI use
• [00:56:34] Claus Crone Fuglsang’s enthusiasm for his work
• [01:00:09] Industrial biotech globally
• [01:04:15] Quick-fire questions